Friday, 15 November 2019

LPD in association with PCO-Why & how?? Steps to avoid such presumed LPD.


 How CL function is adversely affected   in  PCOS women due to its(PCO) persistent hyperinsulinaemic effect: :-- In ovulatory PCOS granulosa cells from polycystic  ovaries   demonstrate   a decreased   ability to   produce and secrete progesterone   in presence of hyperinsulinemia  . This could result from insulin mediated   abnormal / altered intracellular glucose pathway defect.
    Infertility in PCO   could be a resultant effect  from dysfunctional  C  L. The common mechanisms of infertility in PCO is  CL dysfunction. –Definition:- Luteal phase deficiency is a consequence  of the corpus  luteum  inability to  produce and sustain an   adequate levels of progesterone. How to diagnose LPD?? This is clinically   1) manifested by short menstrual cycles and 2) infertility .
Why LPD’ :What is the Etiology of PCO associated LPD ?? :-1) Abnormal   follicular   development, 2) defects in neo angiogenesis or 3) inadequate steroidogenesis   in the lutein cells of the CL have been   implicated in CL dysfunction and LPD. LPD and polycystic ovary syndrome  are independent  disorders   but sharing common pathophysiological  profiles in the sense of  hyperinsulinaemia as the primary defect. . Factors   such as 1)  hyperinsulinemia 2)  AMH excess and  3) defects in angiogenesis of CL are at the origin of both   PCO & LPD.

LPD  and PCOS. Luteal phase  defect an ovulatory   dysfunction  is defined as a defect   of the corpus luteum  to produce  and secrete adequate   amounts  of progesterone   during the luteal phase   of the menstrual cycle . it  includes  the defect of the CL to  preserve   high levels  of progesterone   during the  second   half of the  menstrual cycle as well as the  defect  of the endometrium to respond  to the circulating progesterone  levels. Polycystic  ovary syndrome is a heterogeneous  disorder of unknown etiology   which   affects 6-10%  of women of reproductive   age. The diagnostic criteria for PCOS  include two of the three following   A) chronic anovulation  or oligomenorrhea B)  clinical or  biochemical hyperandrogenism and C)  polycystic ovarian morphology . The pathogenesis   of PCO  is  not clarified as yet LPD and PCOS  are independent disorders but  they share common pathophysiological  profiles .   Although  the literature on this matter is  limited it would be interesting  to investigate in what extent LPD is involved  in subfertility observed  in women  with PCOS .
Etiology and pathogenesis   of corpus  luteum deficiency
Clinically   , LPD may present   with short menstrual cycles or without   any significant change in menstrual cycle length despite prolonged   follicular phases and shortened progesterone deficient luteal  phases . LPD is a clinical   expression of CL   deficiency caused by various   pathophysiological   mechanisms including   abnormal follicular   development   and secretory dysfunction of CL.

 Both  mechanisms lead  to the inadequate transformation   of the endometrium lead  to the inadequate  transformation  of the endometrium to secretory   resulting   in defective implantation of the  blastocyst and deficient   embryonic development.
Polycystic ovary   syndrome
As previously mentioned PCOS is one of the most common female   endocrine   disorders. It is  a complex   syndrome of unclear etiogy pathogenesis characterized by heterogenecity in phenotypic manifestations .Although the pathogenesis  of PCOS remains   unclear the syndrome   appears to  involve environmental and genetic  components   . Oligo  anovulation  in PCOS is likely to be   cause of infertility .  Nevertheless  the role of the CL  quality is not well investigated.
Common factors in LPD  and PCOS
Defect 1:-Hyperinsulinemia in LPD association with PCOS
Hyperinsulinemia seems to have a key role  in the pathogenesis of PCOS. Insulin induces  androgen   production in  multiple ways , it a) directly acts on the ovaries   where it stimulates production  ans secretion of  androgens from the thecae cells  b) acting indirectly it inhibits  the synthesis  of steroid hormone  binding globulin  in the liver , leading  to elevated   free androgen levels   Insulin also been   shown to c)  alter the synthesis  and pulsatile pattern of LH and FSH   secretion and therefore    hinders ovulation.
Defect 2:-In women with PCOS  there is   constant increase GnRH  pulsatility is   increased favoring  the LH over FSH  production and secretion which is a common feature  in women with  syndrome Pulsatile GnRH  secretory pattern  is deranged in both LPD   and PCOS. In women with LPD  previous   studies  have   shown that GnRH  pulse frequency    is normal or increased in the follicular   phase    and suppressed during the luteal  phase. In contrast to PCOS in which    there is a constant increase  of GnRH  pulsatility .
Furthermore  it has been  shown that in ovulatory   women with   polycystic  ovaries there is a Defect 3 :-defect  in luteal phase progesterone excretion . As a result   these women  have lower   levels of progesterone in the early luteal phase which may be implicated in their infertility Hyperinsulinemia  and insulin   resistance may be in part   responsible  for LPD in PCOS   women .

Granulosa cells from polycystic ovaries   demonstrate   a decreased   ability to   produce ad secrete progesterone   in presence of hyperinsulinemia. Defect 4 :-This could result from insulin mediated   glucose     metabolism   in PCO granulosa cells   due to  intracellular   pathways defect. Defect 5  :-Hyperinsulinemia  may also   cause LPD via its direct   effects on the pituitary gland . Plasma  concentrations   of LH  and insulin have  been demonstrated to be  positively correlated   during the luteal phase.
Anti Mullerian  hormone in LPD and PCOS
AMH is a member  of the transforming growth  factor B  superfamily and is a protein produced by fetal  Sertoli cells in order to promote   the Mullerian   duct regression during   testicular    differentiation  in the male fetus . In the ovaries  AMH is expressed by the granulosa cells of primodial follicles  and seems to inhibit  the recruitment  of follicles from  the resting pool to the growing  phase . It is  well established  that serum AMH  levels   are higher  in women with PCOS  compared to healthy controls. AMH   can negatively affect   the   function of granulose lutein cells.
AMH  has been   shown to  1)  inhibit   in culture the proliferation and the progesterone   production of human   granulosa   derived lutein cells  and also  2)  AMH also reduced the expression  of LH   receptors  as well as  3) reduces  the activity  of aromatase in cultured human granulosa   derived    lutein   cells. Therefore    increased   levels of AMH   in PCOS  can be   responsible   for CL dysfunction and LPD  although   further   investigation are required to support this.
How abnormal IS angionegenesis  in LPD and PCOS
Angiogenesis is crucial  for the formation and function of CL as the newly   formed blood vessels provide the CL with nutrients   and low   density   lipoproteins   required  for steroidogenesis . Under  this perspective alterations in concentrations and / or expression   patterns of angiogenic   factors may lead to  luteal function.
Decreased VEGF levels is the chief cause in PCO induced LPD:_  In   fact inhibition of vascular  endothelial growth factor during  the luteal phase    leads to impaired  angiogenesis in the CL and has been  associated  with reduced  progesterone   production and secretion. Therefore  decreased VEGF levels  can  eventually lead to LPD. But  further studies  are required to support  this  .

 In contrast VEGF  levels are increased  in PCOS ans also  temporally  and spatially different  in compared to normal   controls.  A recent animal study   suggests a novel auto / paracrine action of cytokines specifically tumor necrosis  factor alpha (TNF-α)    on the up regulation of VEGF  for angiogenesis stimulation in equine early CL.
Possibly this is  a result of increased sensitivity of lutein granulosa cells of  polycystic ovaries   to insulin which leads to increased VEGF  production in compared to normal ovaries . Although controversy   exists it is possible that impaired   angiogenesis may be a  cause of LPD in PCOS . The other angiogenic  factors such  as angiopoietins , epidermal growth factors,  insulin like  growth factors   fibroblast   growth  factor 1 and 2 also participate  in luteal angiogenesis  but it is not known  whether   these factors  are involved in the pathogenesis of LPD.
Treatment  of LPD should target  to normalize menstrual abnormalities  and improve pregnancy   rates. As  LPD is a multifactorial   disorder   individualized approach   of the patient is  necessary  . Administration of progesterone    or human chorionic   gonadotropin is the most  common treatment   of LPD. Ovulation can be  induced by clomiphene  citrate   and / or  gonadotropin.Decreased VEGF levels is the chief cause in PCO induced LPD:_  In   fact inhibition of vascular  endothelial growth factor during  the luteal phase    leads to impaired  angiogenesis in the CL and has been  associated  with reduced  progesterone   production and secretion. Therefore  decreased VEGF levels  can  eventually lead to LPD. But  further studies  are required to support  this  .



No comments:

Post a Comment